Pharma & Healthcare
Parkinson’s Disease Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 548689
- Pages: 122
- Figures: 209
- Views: 1
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The global market for Parkinson’s Disease Therapeutics was estimated to be worth US$ 2337.8 million in 2023 and is forecast to a readjusted size of US$ 3533.7 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parkinson’s Disease Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Parkinson’s Disease Therapeutics by region & country, by Type, and by Application.
The Parkinson’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson’s Disease Therapeutics.
Market Segmentation
By Company
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Segment by Type:
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Parkinson’s Disease Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Parkinson’s Disease Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Parkinson’s Disease Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Parkinson’s Disease Therapeutics was estimated to be worth US$ 2337.8 million in 2023 and is forecast to a readjusted size of US$ 3533.7 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parkinson’s Disease Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Parkinson’s Disease Therapeutics by region & country, by Type, and by Application.
The Parkinson’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson’s Disease Therapeutics.
Market Segmentation
By Company
Abbvie
Biogen
Boehringer Ingelheim GmbH
F. Hoffman-La Roche
GlaxoSmithKline
H. Lundbeck A/S
Impax Labs
Newron Pharmaceuticals SpA
Novartis AG
Orion Corporation
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Livzon Pharmaceutical
Haisco Pharmaceutical
Jingxin Pharmaceutical
Dongcheng Biochemicals
Segment by Type:
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Parkinson’s Disease Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Parkinson’s Disease Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Parkinson’s Disease Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Parkinson’s Disease Therapeutics Product Introduction
1.2 Global Parkinson’s Disease Therapeutics Market Size Forecast
1.3 Parkinson’s Disease Therapeutics Market Trends & Drivers
1.3.1 Parkinson’s Disease Therapeutics Industry Trends
1.3.2 Parkinson’s Disease Therapeutics Market Drivers & Opportunity
1.3.3 Parkinson’s Disease Therapeutics Market Challenges
1.3.4 Parkinson’s Disease Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Parkinson’s Disease Therapeutics Players Revenue Ranking (2023)
2.2 Global Parkinson’s Disease Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Parkinson’s Disease Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Parkinson’s Disease Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Parkinson’s Disease Therapeutics
2.6 Parkinson’s Disease Therapeutics Market Competitive Analysis
2.6.1 Parkinson’s Disease Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Parkinson’s Disease Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Transdermal
3.1.3 Subcutaneous
3.1.4 Intestinal Infusion
3.2 Global Parkinson’s Disease Therapeutics Sales Value by Type
3.2.1 Global Parkinson’s Disease Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Parkinson’s Disease Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Parkinson’s Disease Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Parkinson’s Disease Therapeutics Sales Value by Application
4.2.1 Global Parkinson’s Disease Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Parkinson’s Disease Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Parkinson’s Disease Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Parkinson’s Disease Therapeutics Sales Value by Region
5.1.1 Global Parkinson’s Disease Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Parkinson’s Disease Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Parkinson’s Disease Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Parkinson’s Disease Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.2.2 North America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.3.2 Europe Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.5.2 South America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value
6.3 United States
6.3.1 United States Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.3.2 United States Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.4.2 Europe Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.5.2 China Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.6.2 Japan Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.9.2 India Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbvie
7.1.1 Abbvie Profile
7.1.2 Abbvie Main Business
7.1.3 Abbvie Parkinson’s Disease Therapeutics Products, Services and Solutions
7.1.4 Abbvie Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Abbvie Recent Developments
7.2 Biogen
7.2.1 Biogen Profile
7.2.2 Biogen Main Business
7.2.3 Biogen Parkinson’s Disease Therapeutics Products, Services and Solutions
7.2.4 Biogen Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Biogen Recent Developments
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Profile
7.3.2 Boehringer Ingelheim GmbH Main Business
7.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Products, Services and Solutions
7.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 F. Hoffman-La Roche Recent Developments
7.4 F. Hoffman-La Roche
7.4.1 F. Hoffman-La Roche Profile
7.4.2 F. Hoffman-La Roche Main Business
7.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Products, Services and Solutions
7.4.4 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 F. Hoffman-La Roche Recent Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Profile
7.5.2 GlaxoSmithKline Main Business
7.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Products, Services and Solutions
7.5.4 GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 GlaxoSmithKline Recent Developments
7.6 H. Lundbeck A/S
7.6.1 H. Lundbeck A/S Profile
7.6.2 H. Lundbeck A/S Main Business
7.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Products, Services and Solutions
7.6.4 H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 H. Lundbeck A/S Recent Developments
7.7 Impax Labs
7.7.1 Impax Labs Profile
7.7.2 Impax Labs Main Business
7.7.3 Impax Labs Parkinson’s Disease Therapeutics Products, Services and Solutions
7.7.4 Impax Labs Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Impax Labs Recent Developments
7.8 Newron Pharmaceuticals SpA
7.8.1 Newron Pharmaceuticals SpA Profile
7.8.2 Newron Pharmaceuticals SpA Main Business
7.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Products, Services and Solutions
7.8.4 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Newron Pharmaceuticals SpA Recent Developments
7.9 Novartis AG
7.9.1 Novartis AG Profile
7.9.2 Novartis AG Main Business
7.9.3 Novartis AG Parkinson’s Disease Therapeutics Products, Services and Solutions
7.9.4 Novartis AG Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Novartis AG Recent Developments
7.10 Orion Corporation
7.10.1 Orion Corporation Profile
7.10.2 Orion Corporation Main Business
7.10.3 Orion Corporation Parkinson’s Disease Therapeutics Products, Services and Solutions
7.10.4 Orion Corporation Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Orion Corporation Recent Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Profile
7.11.2 Teva Pharmaceutical Industries Ltd. Main Business
7.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Products, Services and Solutions
7.11.4 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7.12 UCB S.A.
7.12.1 UCB S.A. Profile
7.12.2 UCB S.A. Main Business
7.12.3 UCB S.A. Parkinson’s Disease Therapeutics Products, Services and Solutions
7.12.4 UCB S.A. Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 UCB S.A. Recent Developments
7.13 Livzon Pharmaceutical
7.13.1 Livzon Pharmaceutical Profile
7.13.2 Livzon Pharmaceutical Main Business
7.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
7.13.4 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Livzon Pharmaceutical Recent Developments
7.14 Haisco Pharmaceutical
7.14.1 Haisco Pharmaceutical Profile
7.14.2 Haisco Pharmaceutical Main Business
7.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
7.14.4 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Haisco Pharmaceutical Recent Developments
7.15 Jingxin Pharmaceutical
7.15.1 Jingxin Pharmaceutical Profile
7.15.2 Jingxin Pharmaceutical Main Business
7.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
7.15.4 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Jingxin Pharmaceutical Recent Developments
7.16 Dongcheng Biochemicals
7.16.1 Dongcheng Biochemicals Profile
7.16.2 Dongcheng Biochemicals Main Business
7.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Products, Services and Solutions
7.16.4 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Dongcheng Biochemicals Recent Developments
8 Industry Chain Analysis
8.1 Parkinson’s Disease Therapeutics Industrial Chain
8.2 Parkinson’s Disease Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Parkinson’s Disease Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Parkinson’s Disease Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Parkinson’s Disease Therapeutics Product Introduction
1.2 Global Parkinson’s Disease Therapeutics Market Size Forecast
1.3 Parkinson’s Disease Therapeutics Market Trends & Drivers
1.3.1 Parkinson’s Disease Therapeutics Industry Trends
1.3.2 Parkinson’s Disease Therapeutics Market Drivers & Opportunity
1.3.3 Parkinson’s Disease Therapeutics Market Challenges
1.3.4 Parkinson’s Disease Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Parkinson’s Disease Therapeutics Players Revenue Ranking (2023)
2.2 Global Parkinson’s Disease Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Parkinson’s Disease Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Parkinson’s Disease Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Parkinson’s Disease Therapeutics
2.6 Parkinson’s Disease Therapeutics Market Competitive Analysis
2.6.1 Parkinson’s Disease Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Parkinson’s Disease Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Transdermal
3.1.3 Subcutaneous
3.1.4 Intestinal Infusion
3.2 Global Parkinson’s Disease Therapeutics Sales Value by Type
3.2.1 Global Parkinson’s Disease Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Parkinson’s Disease Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Parkinson’s Disease Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Parkinson’s Disease Therapeutics Sales Value by Application
4.2.1 Global Parkinson’s Disease Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Parkinson’s Disease Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Parkinson’s Disease Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Parkinson’s Disease Therapeutics Sales Value by Region
5.1.1 Global Parkinson’s Disease Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Parkinson’s Disease Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Parkinson’s Disease Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Parkinson’s Disease Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.2.2 North America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.3.2 Europe Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.5.2 South America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Parkinson’s Disease Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value
6.3 United States
6.3.1 United States Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.3.2 United States Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.4.2 Europe Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.5.2 China Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.6.2 Japan Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Parkinson’s Disease Therapeutics Sales Value, 2019-2030
6.9.2 India Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Parkinson’s Disease Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbvie
7.1.1 Abbvie Profile
7.1.2 Abbvie Main Business
7.1.3 Abbvie Parkinson’s Disease Therapeutics Products, Services and Solutions
7.1.4 Abbvie Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Abbvie Recent Developments
7.2 Biogen
7.2.1 Biogen Profile
7.2.2 Biogen Main Business
7.2.3 Biogen Parkinson’s Disease Therapeutics Products, Services and Solutions
7.2.4 Biogen Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Biogen Recent Developments
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Profile
7.3.2 Boehringer Ingelheim GmbH Main Business
7.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Products, Services and Solutions
7.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 F. Hoffman-La Roche Recent Developments
7.4 F. Hoffman-La Roche
7.4.1 F. Hoffman-La Roche Profile
7.4.2 F. Hoffman-La Roche Main Business
7.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Products, Services and Solutions
7.4.4 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 F. Hoffman-La Roche Recent Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Profile
7.5.2 GlaxoSmithKline Main Business
7.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Products, Services and Solutions
7.5.4 GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 GlaxoSmithKline Recent Developments
7.6 H. Lundbeck A/S
7.6.1 H. Lundbeck A/S Profile
7.6.2 H. Lundbeck A/S Main Business
7.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Products, Services and Solutions
7.6.4 H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 H. Lundbeck A/S Recent Developments
7.7 Impax Labs
7.7.1 Impax Labs Profile
7.7.2 Impax Labs Main Business
7.7.3 Impax Labs Parkinson’s Disease Therapeutics Products, Services and Solutions
7.7.4 Impax Labs Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Impax Labs Recent Developments
7.8 Newron Pharmaceuticals SpA
7.8.1 Newron Pharmaceuticals SpA Profile
7.8.2 Newron Pharmaceuticals SpA Main Business
7.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Products, Services and Solutions
7.8.4 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Newron Pharmaceuticals SpA Recent Developments
7.9 Novartis AG
7.9.1 Novartis AG Profile
7.9.2 Novartis AG Main Business
7.9.3 Novartis AG Parkinson’s Disease Therapeutics Products, Services and Solutions
7.9.4 Novartis AG Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Novartis AG Recent Developments
7.10 Orion Corporation
7.10.1 Orion Corporation Profile
7.10.2 Orion Corporation Main Business
7.10.3 Orion Corporation Parkinson’s Disease Therapeutics Products, Services and Solutions
7.10.4 Orion Corporation Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Orion Corporation Recent Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Profile
7.11.2 Teva Pharmaceutical Industries Ltd. Main Business
7.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Products, Services and Solutions
7.11.4 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7.12 UCB S.A.
7.12.1 UCB S.A. Profile
7.12.2 UCB S.A. Main Business
7.12.3 UCB S.A. Parkinson’s Disease Therapeutics Products, Services and Solutions
7.12.4 UCB S.A. Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 UCB S.A. Recent Developments
7.13 Livzon Pharmaceutical
7.13.1 Livzon Pharmaceutical Profile
7.13.2 Livzon Pharmaceutical Main Business
7.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
7.13.4 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Livzon Pharmaceutical Recent Developments
7.14 Haisco Pharmaceutical
7.14.1 Haisco Pharmaceutical Profile
7.14.2 Haisco Pharmaceutical Main Business
7.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
7.14.4 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 Haisco Pharmaceutical Recent Developments
7.15 Jingxin Pharmaceutical
7.15.1 Jingxin Pharmaceutical Profile
7.15.2 Jingxin Pharmaceutical Main Business
7.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
7.15.4 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Jingxin Pharmaceutical Recent Developments
7.16 Dongcheng Biochemicals
7.16.1 Dongcheng Biochemicals Profile
7.16.2 Dongcheng Biochemicals Main Business
7.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Products, Services and Solutions
7.16.4 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Dongcheng Biochemicals Recent Developments
8 Industry Chain Analysis
8.1 Parkinson’s Disease Therapeutics Industrial Chain
8.2 Parkinson’s Disease Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Parkinson’s Disease Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Parkinson’s Disease Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Parkinson’s Disease Therapeutics Market Trends
Table 2. Parkinson’s Disease Therapeutics Market Drivers & Opportunity
Table 3. Parkinson’s Disease Therapeutics Market Challenges
Table 4. Parkinson’s Disease Therapeutics Market Restraints
Table 5. Global Parkinson’s Disease Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Parkinson’s Disease Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Parkinson’s Disease Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Parkinson’s Disease Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Parkinson’s Disease Therapeutics
Table 10. Global Parkinson’s Disease Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Parkinson’s Disease Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Parkinson’s Disease Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Parkinson’s Disease Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Parkinson’s Disease Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Parkinson’s Disease Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Parkinson’s Disease Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Parkinson’s Disease Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Parkinson’s Disease Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Parkinson’s Disease Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Parkinson’s Disease Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Parkinson’s Disease Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbvie Basic Information List
Table 32. Abbvie Description and Business Overview
Table 33. Abbvie Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Abbvie (2019-2024)
Table 35. Abbvie Recent Developments
Table 36. Biogen Basic Information List
Table 37. Biogen Description and Business Overview
Table 38. Biogen Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Biogen (2019-2024)
Table 40. Biogen Recent Developments
Table 41. Boehringer Ingelheim GmbH Basic Information List
Table 42. Boehringer Ingelheim GmbH Description and Business Overview
Table 43. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Boehringer Ingelheim GmbH (2019-2024)
Table 45. Boehringer Ingelheim GmbH Recent Developments
Table 46. F. Hoffman-La Roche Basic Information List
Table 47. F. Hoffman-La Roche Description and Business Overview
Table 48. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of F. Hoffman-La Roche (2019-2024)
Table 50. F. Hoffman-La Roche Recent Developments
Table 51. GlaxoSmithKline Basic Information List
Table 52. GlaxoSmithKline Description and Business Overview
Table 53. GlaxoSmithKline Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of GlaxoSmithKline (2019-2024)
Table 55. GlaxoSmithKline Recent Developments
Table 56. H. Lundbeck A/S Basic Information List
Table 57. H. Lundbeck A/S Description and Business Overview
Table 58. H. Lundbeck A/S Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of H. Lundbeck A/S (2019-2024)
Table 60. H. Lundbeck A/S Recent Developments
Table 61. Impax Labs Basic Information List
Table 62. Impax Labs Description and Business Overview
Table 63. Impax Labs Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Impax Labs (2019-2024)
Table 65. Impax Labs Recent Developments
Table 66. Newron Pharmaceuticals SpA Basic Information List
Table 67. Newron Pharmaceuticals SpA Description and Business Overview
Table 68. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Newron Pharmaceuticals SpA (2019-2024)
Table 70. Newron Pharmaceuticals SpA Recent Developments
Table 71. Novartis AG Basic Information List
Table 72. Novartis AG Description and Business Overview
Table 73. Novartis AG Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Novartis AG (2019-2024)
Table 75. Novartis AG Recent Developments
Table 76. Orion Corporation Basic Information List
Table 77. Orion Corporation Description and Business Overview
Table 78. Orion Corporation Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Orion Corporation (2019-2024)
Table 80. Orion Corporation Recent Developments
Table 81. Teva Pharmaceutical Industries Ltd. Basic Information List
Table 82. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 83. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Teva Pharmaceutical Industries Ltd. (2019-2024)
Table 85. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 86. UCB S.A. Basic Information List
Table 87. UCB S.A. Description and Business Overview
Table 88. UCB S.A. Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of UCB S.A. (2019-2024)
Table 90. UCB S.A. Recent Developments
Table 91. Livzon Pharmaceutical Basic Information List
Table 92. Livzon Pharmaceutical Description and Business Overview
Table 93. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Livzon Pharmaceutical (2019-2024)
Table 95. Livzon Pharmaceutical Recent Developments
Table 96. Haisco Pharmaceutical Basic Information List
Table 97. Haisco Pharmaceutical Description and Business Overview
Table 98. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Haisco Pharmaceutical (2019-2024)
Table 100. Haisco Pharmaceutical Recent Developments
Table 101. Jingxin Pharmaceutical Basic Information List
Table 102. Jingxin Pharmaceutical Description and Business Overview
Table 103. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Jingxin Pharmaceutical (2019-2024)
Table 105. Jingxin Pharmaceutical Recent Developments
Table 106. Dongcheng Biochemicals Basic Information List
Table 107. Dongcheng Biochemicals Description and Business Overview
Table 108. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Dongcheng Biochemicals (2019-2024)
Table 110. Dongcheng Biochemicals Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Parkinson’s Disease Therapeutics Downstream Customers
Table 114. Parkinson’s Disease Therapeutics Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Parkinson’s Disease Therapeutics Product Picture
Figure 2. Global Parkinson’s Disease Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Parkinson’s Disease Therapeutics Report Years Considered
Figure 5. Global Parkinson’s Disease Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinson’s Disease Therapeutics Revenue in 2023
Figure 7. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Oral Picture
Figure 9. Transdermal Picture
Figure 10. Subcutaneous Picture
Figure 11. Intestinal Infusion Picture
Figure 12. Global Parkinson’s Disease Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Parkinson’s Disease Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Clinics
Figure 16. Product Picture of Others
Figure 17. Global Parkinson’s Disease Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Parkinson’s Disease Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value (%), (2019-2030)
Figure 30. United States Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. China Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. China Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. India Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 50. India Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 51. Parkinson’s Disease Therapeutics Industrial Chain
Figure 52. Parkinson’s Disease Therapeutics Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Parkinson’s Disease Therapeutics Market Trends
Table 2. Parkinson’s Disease Therapeutics Market Drivers & Opportunity
Table 3. Parkinson’s Disease Therapeutics Market Challenges
Table 4. Parkinson’s Disease Therapeutics Market Restraints
Table 5. Global Parkinson’s Disease Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Parkinson’s Disease Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Parkinson’s Disease Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Parkinson’s Disease Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Parkinson’s Disease Therapeutics
Table 10. Global Parkinson’s Disease Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Parkinson’s Disease Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Parkinson’s Disease Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Parkinson’s Disease Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Parkinson’s Disease Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Parkinson’s Disease Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Parkinson’s Disease Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Parkinson’s Disease Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Parkinson’s Disease Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Parkinson’s Disease Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Parkinson’s Disease Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Parkinson’s Disease Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Parkinson’s Disease Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbvie Basic Information List
Table 32. Abbvie Description and Business Overview
Table 33. Abbvie Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Abbvie (2019-2024)
Table 35. Abbvie Recent Developments
Table 36. Biogen Basic Information List
Table 37. Biogen Description and Business Overview
Table 38. Biogen Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Biogen (2019-2024)
Table 40. Biogen Recent Developments
Table 41. Boehringer Ingelheim GmbH Basic Information List
Table 42. Boehringer Ingelheim GmbH Description and Business Overview
Table 43. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Boehringer Ingelheim GmbH (2019-2024)
Table 45. Boehringer Ingelheim GmbH Recent Developments
Table 46. F. Hoffman-La Roche Basic Information List
Table 47. F. Hoffman-La Roche Description and Business Overview
Table 48. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of F. Hoffman-La Roche (2019-2024)
Table 50. F. Hoffman-La Roche Recent Developments
Table 51. GlaxoSmithKline Basic Information List
Table 52. GlaxoSmithKline Description and Business Overview
Table 53. GlaxoSmithKline Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of GlaxoSmithKline (2019-2024)
Table 55. GlaxoSmithKline Recent Developments
Table 56. H. Lundbeck A/S Basic Information List
Table 57. H. Lundbeck A/S Description and Business Overview
Table 58. H. Lundbeck A/S Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of H. Lundbeck A/S (2019-2024)
Table 60. H. Lundbeck A/S Recent Developments
Table 61. Impax Labs Basic Information List
Table 62. Impax Labs Description and Business Overview
Table 63. Impax Labs Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Impax Labs (2019-2024)
Table 65. Impax Labs Recent Developments
Table 66. Newron Pharmaceuticals SpA Basic Information List
Table 67. Newron Pharmaceuticals SpA Description and Business Overview
Table 68. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Newron Pharmaceuticals SpA (2019-2024)
Table 70. Newron Pharmaceuticals SpA Recent Developments
Table 71. Novartis AG Basic Information List
Table 72. Novartis AG Description and Business Overview
Table 73. Novartis AG Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Novartis AG (2019-2024)
Table 75. Novartis AG Recent Developments
Table 76. Orion Corporation Basic Information List
Table 77. Orion Corporation Description and Business Overview
Table 78. Orion Corporation Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Orion Corporation (2019-2024)
Table 80. Orion Corporation Recent Developments
Table 81. Teva Pharmaceutical Industries Ltd. Basic Information List
Table 82. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 83. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Teva Pharmaceutical Industries Ltd. (2019-2024)
Table 85. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 86. UCB S.A. Basic Information List
Table 87. UCB S.A. Description and Business Overview
Table 88. UCB S.A. Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of UCB S.A. (2019-2024)
Table 90. UCB S.A. Recent Developments
Table 91. Livzon Pharmaceutical Basic Information List
Table 92. Livzon Pharmaceutical Description and Business Overview
Table 93. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Livzon Pharmaceutical (2019-2024)
Table 95. Livzon Pharmaceutical Recent Developments
Table 96. Haisco Pharmaceutical Basic Information List
Table 97. Haisco Pharmaceutical Description and Business Overview
Table 98. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Haisco Pharmaceutical (2019-2024)
Table 100. Haisco Pharmaceutical Recent Developments
Table 101. Jingxin Pharmaceutical Basic Information List
Table 102. Jingxin Pharmaceutical Description and Business Overview
Table 103. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Jingxin Pharmaceutical (2019-2024)
Table 105. Jingxin Pharmaceutical Recent Developments
Table 106. Dongcheng Biochemicals Basic Information List
Table 107. Dongcheng Biochemicals Description and Business Overview
Table 108. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Parkinson’s Disease Therapeutics Business of Dongcheng Biochemicals (2019-2024)
Table 110. Dongcheng Biochemicals Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Parkinson’s Disease Therapeutics Downstream Customers
Table 114. Parkinson’s Disease Therapeutics Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Parkinson’s Disease Therapeutics Product Picture
Figure 2. Global Parkinson’s Disease Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Parkinson’s Disease Therapeutics Report Years Considered
Figure 5. Global Parkinson’s Disease Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinson’s Disease Therapeutics Revenue in 2023
Figure 7. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Oral Picture
Figure 9. Transdermal Picture
Figure 10. Subcutaneous Picture
Figure 11. Intestinal Infusion Picture
Figure 12. Global Parkinson’s Disease Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Parkinson’s Disease Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Clinics
Figure 16. Product Picture of Others
Figure 17. Global Parkinson’s Disease Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Parkinson’s Disease Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Parkinson’s Disease Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Parkinson’s Disease Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Parkinson’s Disease Therapeutics Sales Value (%), (2019-2030)
Figure 30. United States Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 36. China Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 38. China Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 48. India Parkinson’s Disease Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Parkinson’s Disease Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 50. India Parkinson’s Disease Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 51. Parkinson’s Disease Therapeutics Industrial Chain
Figure 52. Parkinson’s Disease Therapeutics Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232